Kovitz Investment Group Partners LLC Invests $1.37 Million in Tempus AI, Inc. (NASDAQ:TEM)

Kovitz Investment Group Partners LLC purchased a new stake in Tempus AI, Inc. (NASDAQ:TEM) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 24,186 shares of the company’s stock, valued at approximately $1,367,000.

Other hedge funds have also added to or reduced their stakes in the company. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI in the 3rd quarter worth $30,000. Vestor Capital LLC bought a new stake in Tempus AI in the 3rd quarter worth about $153,000. The Manufacturers Life Insurance Company grew its position in Tempus AI by 10.2% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 29,789 shares of the company’s stock worth $1,686,000 after purchasing an additional 2,765 shares in the last quarter. Stifel Financial Corp bought a new position in shares of Tempus AI during the 3rd quarter worth approximately $218,000. Finally, Sandia Investment Management LP purchased a new position in shares of Tempus AI in the 2nd quarter worth approximately $136,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently commented on TEM shares. Loop Capital increased their price target on Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. Guggenheim assumed coverage on Tempus AI in a research report on Monday. They set a “buy” rating and a $74.00 target price for the company. Bank of America downgraded shares of Tempus AI from a “buy” rating to a “neutral” rating and boosted their price target for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Piper Sandler restated a “neutral” rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Finally, Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and boosted their target price for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $56.20.

Tempus AI Trading Down 3.2 %

Shares of NASDAQ:TEM opened at $45.00 on Wednesday. The stock’s 50-day simple moving average is $53.18. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $79.49. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.